Is Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) hereditary?

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is indeed a hereditary disorder. It is caused by mutations in the TYMP gene, which is responsible for producing an enzyme called thymidine phosphorylase. This enzyme plays a crucial role in the breakdown of certain molecules in the body.

Individuals with MNGIE inherit two copies of the mutated gene, one from each parent. This means that the disorder follows an autosomal recessive pattern of inheritance. In other words, both parents must carry a copy of the mutated gene for their child to be affected.

Due to the mutations in the TYMP gene, individuals with MNGIE experience a buildup of toxic substances, such as thymidine and deoxyuridine, in their cells. This accumulation primarily affects tissues with high energy demands, including the nervous system, gastrointestinal tract, and skeletal muscles.

Common symptoms of MNGIE include gastrointestinal problems (such as severe diarrhea, vomiting, and weight loss), muscle weakness, peripheral neuropathy, and progressive neurological deterioration. These symptoms typically appear in late childhood or early adulthood.

Diagnosis of MNGIE involves genetic testing to identify mutations in the TYMP gene. Unfortunately, there is currently no cure for MNGIE, and treatment mainly focuses on managing the symptoms and improving the patient's quality of life.

Genetic counseling is crucial for individuals with a family history of MNGIE or those who have been diagnosed with the disorder. It can help them understand the inheritance pattern, assess the risk of passing on the condition to their children, and explore available reproductive options.